Evidence map›Paper›PMID 22705848›Full record

ArticleCell death and differentiation2012

DNA damage response by single-strand breaks in terminally differentiated muscle cells and the control of muscle integrity.

P Fortini, C Ferretti, B Pascucci, L Narciso, D Pajalunga, E M R Puggioni, R Castino, C Isidoro, M Crescenzi, E Dogliotti

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. In vivo analysis of γH2AX+ cells in skeletal muscle from aged and obese humans.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

P FortiniDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
C Ferretti
B Pascucci
L Narciso
D Pajalunga
E M R Puggioni
R Castino
C Isidoro
M Crescenzi
E Dogliotti
Istituto Superiore di Sanità · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITInstitute of Crystallography · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA single-strand breaks (SSB) formation coordinates the myogenic program, and defects in SSB repair in post-mitotic cells have been associated with human diseases. However, the DNA damage response by SSB in terminally differentiated cells has not been explored yet. Here we show that mouse post-mitotic muscle cells accumulate SSB after alkylation damage, but they are extraordinarily resistant to the killing effects of a variety of SSB-inducers. We demonstrate that, upon SSB induction, phosphorylation of H2AX occurs in myotubes and is largely ataxia telangiectasia mutated (ATM)-dependent. However, the DNA damage signaling cascade downstream of ATM is defective as shown by lack of p53 increase and phosphorylation at serine 18 (human serine 15). The stabilization of p53 by nutlin-3 was ineffective in activating the cell death pathway, indicating that the resistance to SSB inducers is due to defective p53 downstream signaling. The induction of specific types of damage is required to activate the cell death program in myotubes. Besides the topoisomerase inhibitor doxorubicin known for its cardiotoxicity, we show that the mitochondria-specific inhibitor menadione is able to activate p53 and to kill effectively myotubes. Cell killing is p53-dependent as demonstrated by full protection of myotubes lacking p53, but there is a restriction of p53-activated genes. This new information may have important therapeutic implications in the prevention of muscle cell toxicity.

Indexed as

DNA Breaks, Single-StrandedDNA RepairAnimalsApoptosisAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell DifferentiationDNA-Binding ProteinsDNA DamageDoxorubicinHistonesImidazolesMiceMuscle Fibers, SkeletalPhosphorylationPiperazinesAtaxia Telangiectasia Mutated ProteinsATM protein, humanAtm protein, mouseCell Cycle ProteinsDNA-Binding ProteinsDoxorubicingamma-H2AX protein, mouseHistonesImidazolesnutlin 3PiperazinesProtein Serine-Threonine KinasesTumor Suppressor Protein p53Tumor Suppressor ProteinsVitamin K 3

Identifiers

PMID22705848
PMCPMC3469061
OpenAlexW2046820022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.